KRAS MUTATION IN EGFR WILD TYPE INDONESIAN LUNG CANCER PATIENT

被引:0
|
作者
Masykura, Najmiatul [1 ]
Kharunisa, Bela Haifa [1 ]
Zaini, Jamal [2 ,3 ]
Andarini, Sita Laksmi [2 ,3 ]
Hudoyo, Achmad [2 ,3 ]
Syahruddin, Elisna [2 ]
Hidajat, Heriawaty [2 ]
Widjajahakim, Grace [4 ]
Utomo, Ahmad [1 ,4 ]
机构
[1] Kalbe Farma Tbk, Stem Cell & Canc Inst, Kota Jakarta Timur, Indonesia
[2] Persahabatan Hosp, Jakarta, Indonesia
[3] Univ Indonesia, Fac Med, Jakarta, Indonesia
[4] Kalbe Genom Lab, Jakarta Timur, Indonesia
关键词
D O I
暂无
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
AO159
引用
收藏
页码:73 / 73
页数:1
相关论文
共 50 条
  • [31] Biomarkers and anti-EGFR therapies for KRAS wild-type metastatic colorectal cancer
    Jose A. García-Sáenz
    Javier Sastre
    Eduardo Díaz-Rubio García
    Clinical and Translational Oncology, 2009, 11 : 737 - 747
  • [32] Early and late brain metastases in EGFR wild type and EGFR mutation positive non small cell lung cancer: Implications for survival.
    Ho, Cheryl
    Yamada, Andrew
    Weber, Britta
    Yuan, Ren
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [33] Correlation between EGFR expression, gene amplification, mutation and KRAS mutation in lung adenocarcinomas
    Dogusoy, G. Bulbul
    Bassullu, N.
    Coban, I.
    Hancer, V.
    Buyukdogan, M.
    Namal, E.
    Toker, A.
    Yasar, R.
    Demir, G.
    VIRCHOWS ARCHIV, 2013, 463 (02) : 240 - 240
  • [34] Optimisation of EGFR TKI efficiency in the therapeutic scheme of EGFR wild-type lung cancer
    Cabart, Mathilde
    Raimbourg, Judith
    Lalier, Lisenn
    Bennouna, Jaafar
    Vallette, Francois
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [35] Tumor Mutation Signature Reveals the Risk Factors of Lung Adenocarcinoma with EGFR or KRAS Mutation
    Wang, Jialiang
    Guo, Chang
    Wang, Jiexiao
    Zhang, Xiaopeng
    Qi, Jian
    Huang, Xiang
    Hu, Zongtao
    Wang, Hongzhi
    Hong, Bo
    CANCER CONTROL, 2025, 32
  • [36] EGFR and KRas Mutation Analysis in Lung Adenocarcinoma: Adequacy of Cytology Samples
    Heymann, J. J.
    Saab, J.
    Zachariah, J.
    Hoda, R. S.
    LABORATORY INVESTIGATION, 2013, 93 : 92A - 92A
  • [37] EGFR and KRas Mutation Analysis in Lung Adenocarcinoma: Adequacy of Cytology Samples
    Heymann, J. J.
    Saab, J.
    Zachariah, J.
    Hoda, R. S.
    MODERN PATHOLOGY, 2013, 26 : 92A - 92A
  • [38] Advances on EGFR mutation for lung cancer
    Metro, Giulio
    Crino, Lucio
    TRANSLATIONAL LUNG CANCER RESEARCH, 2012, 1 (01) : 5 - 13
  • [39] Pulmonary Inflammation and KRAS Mutation in Lung Cancer
    Keohavong, Phouthone
    Di, Y. Peter
    LUNG INFLAMMATION IN HEALTH AND DISEASE, VOL I, 2021, 1303 : 71 - 87
  • [40] EGFR inhibition is effective against KRAS-wild-type disease
    Peter Sidaway
    Nature Reviews Clinical Oncology, 2017, 14 : 525 - 525